Peyronie Disease
20
6
7
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 20 trials
100.0%
+13.5% vs benchmark
10%
2 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (20)
Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease
Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease
Pilot Study on the Efficacy and Safety of FIBRORESTIL® as an Adjuvant Intralesional Treatment in Patients With Peyronie's Disease Receiving Standard Therapy
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
PRP for Treatment of Peyronie's Disease
Platelet-Rich Plasma Injections From Cord Blood + Penile Traction vs. Penile Traction Alone in Patients With Peyronie's Disease. Open-label, Single-center Randomized Study
Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease
Safety and Efficacy of Intralesional HiLow Hyaluronic Acid in the Treatment of Peyronie's Disease (PD)
Peyronie Disease Questionnaire (PDQ): Turkish Validation
Pelvic CT with Agatston Calcium Score for Peyronie Disease
French Translation and Validation of the PEYronie's Disease QUESTionnaire
Safety and Efficacy of Low-intensity Shockwave Therapy for Peyronie's Disease
Non-ablative Radiofrequency and Low Intensity Shock Wave Therapy in Fibrotic Plaque in Men With Peyronie's Disease
Focused Shock Wave Therapy Outcomes in Peyronie's Disease and Erectile Dysfunction
Novel Nanofat Regenerative Surgical Technique for Peyronies' Disease Treatment
Treatment Response to Xiaflex for Men With Peyronie's Disease
Medical Treatment of Peyronie's Disease With Collagenase Clostridium Histolyticum
Does Size Matter: A Single Case Experimental Design of Limiting the Depth of Penetration During Intercourse
Low-Intensity Extracorporeal Shockwave Therapy and Vacuum Erectile Device as a Treatment for Peyronies Disease.
Management of Peyronie's Disease With Adipose Tissue Stem Cell